• Navigating Pharma Supply Chains through a BANI World
    Oct 7 2025

    This kickoff to our BANI mini‑series unpacks how brittle, anxious, non‑linear and incomprehensible dynamics are reshaping pharma supply chains.

    We discuss real‑world brittleness: a 7.4‑magnitude earthquake in Japan that halted chip production and ground Detroit’s auto assembly, and a software update that locked up millions of computers and grounded.

    We examine how U.S. tariffs on Chinese imports have pushed logistics costs up 10–15 % for 60 % of companies and how Houthi attacks have closed the Red Sea shipping route, forcing vessels to detour around the Cape of Good Hope, adding up to 12 days and roughly US $1 million per voyage.

    We also highlight China’s dominance in pharma ingredients, producing more than 80 % of API, and why geopolitical instability tops risk forecasts for 2026.

    Más Menos
    5 m
  • Responsible AI: Are we losing the Human in the Process?
    Jul 19 2025

    In this episode, I reflect on the growing trend of AI being used to cut jobs, often without a clear plan for reskilling or redeployment.

    Triggered by a recent New York Times article mentioning layoffs at companies like Microsoft and Recruit Holdings,

    I question whether we’re losing the human in the process.

    AI isn’t the problem. It’s how we choose to implement it that matters.

    Here is the link to my whitepaper on this topic:

    The Social Impact of AI: Rethinking Corporate Responsibility in the Age of Intelligent Transformation | LinkedIn

    Más Menos
    2 m
  • Pharma SCM meets AI @ CPhI 2024 in Milan
    Oct 13 2024

    In this episode I am summarizing my experience at the CPhI 2024 in Milan, Italy.

    Find out what I found out in the city of fashion, art, food and now also Pharma.

    Enjoy!

    Más Menos
    3 m
  • Supply Chain Quo Vadis - How identified challenges become opportunities - or not?
    Oct 3 2024

    In this episode we will dive into how identified challenges in supply chain management become opportunities - or maybe not?

    Más Menos
    6 m
  • Artificial Intelligence (AI) in Pharmaceutical Manufacturing
    Sep 22 2024

    Today's episode focuses on the role of AI in Pharmaceutical Manufacturing, specifically how it is powering personalized medicine.

    We will explore AI's impact today and what the future looks like by 2030, with technologies like digital twins driving efficiency and precision in drug development.

    Más Menos
    6 m
  • Generative AI: The New Frontier in Supply Chain Management
    Sep 20 2024

    I'm excited to share my first episode of my podcast, where I dive into one of the hottest topics in the logistics and supply chain world—Generative AI!

    This groundbreaking technology is reshaping supply chain management, from demand forecasting to real-time logistics optimization.

    In this episode, you'll learn:

    - How generative AI is revolutionizing inventory management

    - Real-world applications driving efficiency in global supply chains

    - The future potential of AI in creating smarter, more resilient supply networks

    - Challenges companies face as they integrate AI into their supply chain ecosystems

    Más Menos
    8 m
  • transport logistic 2025 Recap – Innovation, Networking & What’s Next
    Jun 7 2025

    In this special episode of Supply-Chain360, I recap the highlights from transport logistic 2025 in Munich. With over 2,300 exhibitors and attendees from 120+ countries, the event showcased cutting-edge logistics tech, global collaboration, and the future of sustainable supply chains. Missed it? Don’t worry – we’ve got you covered in under 2 minutes.

    Más Menos
    2 m
  • Talent Management - A balanced approach to Leadership and Followership
    Dec 5 2024

    Welcome to this special episode of my podcast, where I explore the critical aspects of Talent Management—not just as a process of developing leaders but as a balanced framework that equally emphasizes followership development.

    Using insights from various scholarly and professional sources, I aim to reshape how organizations think about managing their most vital asset: People.

    Más Menos
    6 m